Article in mSystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Jingyi Guo *Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.ORCID 0009-0007-6314-7711
Haotian Xu *School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.
Chengjin Wu *Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Hongyan YuThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lexuan YangLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Yan QiMedical Laboratory Center, Hangzhou TCM Hospital Affiliated to the Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xiuyun ZuoDepartment of Clinical Laboratory, Feicheng Hospital of Traditional Chinese Medicine, Feicheng, Shandong, China.
Hongyin YangDepartment of Clinical Laboratory, Feicheng Hospital of Traditional Chinese Medicine, Feicheng, Shandong, China.
Linyue ZhangDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.ORCID 0000-0002-0623-4727
Yunsong YuLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.ORCID 0000-0003-2903-918X
Xi LiLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.ORCID 0000-0002-8838-7814
Funding
Key Research and Development Program of Zhejiang Province (Key R&D plan of Zhejiang Province) 2023C03068National Health Commission Scientific Research Fund-Zhejiang Provincial Major Health Science and Technology Plan Project WKJ-ZJ-2414National Natural Science Foundation of China 82402665National Natural Science Foundation of China 82472323,82172306Zhejiang Province Natural Science Foundation Outstanding Youth Program LR25H200001
6 · The paper itself
Abstract
Carbapenem-resistant IMPORTANCE: To date, the phylogeographic distribution of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Global phylogeography and genomic characterization of · full record | OpenQuestion